Clinical Trials Browser

Withdrawn × Leukemia × Bortezomib × Clear all

NCT01162031 2018-05-21

Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia

Phase 2 Withdrawn

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma